Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Marie Krzesinski

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Revue Medicale De Liege|June 13, 2024
[How to manage arterial hypertension in 2024 to optimize cardiorenal protection]Jean-Marie Krzesinski
Revue Medicale De Liege|June 23, 2023
[Functional disorder and arterial hypotension]Jean-Marie Krzesinski
Revue Medicale Suisse|August 25, 2017
[Proton-pump inhibitors and risk of kidney disease]François Paquot, Jean-Marie Krzesinski
Nephron. Clinical Practice|September 22, 2011
Indexing of renal function parameters by body surface area: intelligence or folly?Pierre Delanaye, Jean-Marie Krzesinski
Revue Medicale Suisse|September 22, 2010
[What is the ideal blood pressure goal for the hypertensive population in 2010? Review of the evidence in the literature]Jean-Marie Krzesinski, Annie Saint-Remy
Core Evidence|August 10, 2010
Exforge (amlodipine/valsartan combination) in hypertension: the evidence of its therapeutic impactJean-Marie Krzesinski, Eric P Cohen
Kidney International|October 31, 2009
C-reactive protein and dialysis accessEric P Cohen, Jean-Marie Krzesinski
Vascular Health and Risk Management|February 27, 2007
Optimal blood pressure level and best measurement procedure in hemodialysis patientsAnnie Saint-Remy, Jean-Marie Krzesinski
Clinical Kidney Journal|August 10, 2018
Genetic susceptibility to delayed graft function following kidney transplantation: a systematic review of the literatureJustine Huart, Jean-Marie Krzesinski, François Jouret
Nephrologie & Therapeutique|January 7, 2014
[Role of AMP-activated protein kinase in renal ischemic preconditioning]Pauline Erpicum, Jean-Marie Krzesinski, François Jouret
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Revue Medicale De Liege|June 13, 2024
[How to manage arterial hypertension in 2024 to optimize cardiorenal protection]Jean-Marie Krzesinski
Revue Medicale De Liege|June 23, 2023
[Functional disorder and arterial hypotension]Jean-Marie Krzesinski
Revue Medicale Suisse|August 25, 2017
[Proton-pump inhibitors and risk of kidney disease]François Paquot, Jean-Marie Krzesinski
Nephron. Clinical Practice|September 22, 2011
Indexing of renal function parameters by body surface area: intelligence or folly?Pierre Delanaye, Jean-Marie Krzesinski
Revue Medicale Suisse|September 22, 2010
[What is the ideal blood pressure goal for the hypertensive population in 2010? Review of the evidence in the literature]Jean-Marie Krzesinski, Annie Saint-Remy
Core Evidence|August 10, 2010
Exforge (amlodipine/valsartan combination) in hypertension: the evidence of its therapeutic impactJean-Marie Krzesinski, Eric P Cohen
Kidney International|October 31, 2009
C-reactive protein and dialysis accessEric P Cohen, Jean-Marie Krzesinski
Vascular Health and Risk Management|February 27, 2007
Optimal blood pressure level and best measurement procedure in hemodialysis patientsAnnie Saint-Remy, Jean-Marie Krzesinski
Clinical Kidney Journal|August 10, 2018
Genetic susceptibility to delayed graft function following kidney transplantation: a systematic review of the literatureJustine Huart, Jean-Marie Krzesinski, François Jouret
Nephrologie & Therapeutique|January 7, 2014
[Role of AMP-activated protein kinase in renal ischemic preconditioning]Pauline Erpicum, Jean-Marie Krzesinski, François Jouret
Pageof 10